Skip to main navigation

Menu

About Us
- Our Team
  - Our Chief Innovator
- Our Network
Technology
Pipeline
MEDIA
Investors
Careers
Get In Touch

News Releases

Year

Rani Therapeutics Announces Research Agreement with Chugai

May 19, 2025

Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update

May 13, 2025

Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update

Mar 31, 2025

Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102

Mar 26, 2025

Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

Mar 25, 2025

Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC

Feb 05, 2025

Print Page
Email Alerts
RSS Feeds
Contact IR

Company

About
Careers
Contact

Resources

News
Applications
Technology

San Jose Office

2051 Ringwood Ave. San Jose CA, 95131

© Rani Therapeutics. All Rights Reserved. Rani, Rani Therapeutics, and RaniPill and their corresponding logos are trademarks or registered trademarks of Rani Therapeutics, LLC in the US and other countries.